Last month the federal government announced that the AstraZeneca vaccine would be phased out, with it being available only ‘on request’ after October of this year. This decision followed numerous blood clotting cases and some deaths occurring following vaccination.
The government will now rely on the Pfizer and Moderna vaccines. However, these mRNA inoculations are not without their problems, either.
Already a subscriber? Log in
Get 10 issues
for $20
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $20.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in